Maintenance treatment with medroxyprogesterone acetate in patients with advanced breast cancer responding to chemotherapy: results of a randomized trial. Essen Breast Cancer Study Group. [electronic resource]
Producer: 19991025Description: 51-9 p. digitalISSN:- 0167-6806
- Aged
- Antineoplastic Agents, Hormonal -- therapeutic use
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Breast Neoplasms -- drug therapy
- Disease-Free Survival
- Epirubicin -- administration & dosage
- Female
- Germany
- Humans
- Ifosfamide -- administration & dosage
- Medroxyprogesterone Acetate -- therapeutic use
- Middle Aged
- Prospective Studies
- Quality of Life
- Survival Analysis
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.